A Bayesian Meta-analysis Method for Estimating Risk Difference of Rare Events
暂无分享,去创建一个
Yuanyuan Tang | Qi Tang | Yao Yu | Shihua Wen | Yuanyuan Tang | Qi Tang | Yao Yu | Shihua Wen
[1] John E. Hunter,et al. Methods of Meta-Analysis , 1989 .
[2] S M Berry. Understanding and testing for heterogeneity across 2 x 2 tables: application to meta-analysis. , 1998, Statistics in medicine.
[3] B. Gersh. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes , 2008 .
[4] Douglas G Altman,et al. Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales by D. E. Warn, S. G. Thompson and D. J. Spiegelhalter, Statistics in Medicine 2002; 21: 1601–1623 , 2005, Statistics in medicine.
[5] Alexander J Sutton,et al. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.
[6] Bradley P Carlin,et al. Network meta-analysis of randomized clinical trials: Reporting the proper summaries , 2014, Clinical trials.
[7] Tianxi Cai,et al. Meta‐analysis for rare events , 2010, Statistics in medicine.
[8] Anup Amatya,et al. Meta-Analysis of Rare Binary Adverse Event Data , 2012, Journal of the American Statistical Association.
[9] Lisa A. Weissfeld,et al. An assessment of the use of the continuity correction for sparse data in meta-analysis , 1996 .
[10] Michael Evans,et al. Checking for prior-data conflict , 2006 .
[11] Jonathan J Deeks,et al. Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events , 2007, Statistics in medicine.
[12] Lu Tian,et al. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction. , 2009, Biostatistics.
[13] Minge Xie,et al. Exact Meta-Analysis Approach for Discrete Data and its Application to 2 × 2 Tables With Rare Events , 2014, Journal of the American Statistical Association.
[14] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[15] J B Carlin,et al. Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting by S-L. T. Normand, Statistics in Medicine, 18, 321-359 (1999) , 2000, Statistics in medicine.
[16] A. Gelman. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .
[17] J. Carlin. Meta-analysis for 2 x 2 tables: a Bayesian approach. , 1992, Statistics in medicine.
[18] Edna Schechtman,et al. Odds ratio, relative risk, absolute risk reduction, and the number needed to treat--which of these should we use? , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[19] Alex J. Sutton,et al. Methods for Meta-Analysis in Medical Research , 2000 .
[20] Dungang Liu,et al. Meta‐analysis framework for exact inferences with application to the analysis of rare events , 2016, Biometrics.
[21] K R Abrams,et al. Bayesian methods in meta-analysis and evidence synthesis. , 2001, Statistical methods in medical research.
[22] Joseph Beyene,et al. Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data , 2007, BMC medical research methodology.
[23] D J Spiegelhalter,et al. Bayesian approaches to random-effects meta-analysis: a comparative study. , 1995, Statistics in medicine.
[24] Peter Cummings,et al. The relative merits of risk ratios and odds ratios. , 2009, Archives of pediatrics & adolescent medicine.